Epithelial cells as sentinels in mucosal immune barrier

Japanese Journal of Clinical Immunology

Volumn 29, Issue 1, 2006, Pages 16-26

  Hase, Koji ^a   Ohno, Hiroshi ^b  

^a Institute of Physical and Chemical Research   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Antimicrobial peptide; Chemokine; Epithelial cells; M cells; Mucosal immunity

Indexed keywords

ANTIGEN; ANTIMICROBIAL CATIONIC PEPTIDE; CHEMOKINE; FC RECEPTOR; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1;

ANIMAL; BIOSYNTHESIS; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; MOUSE; MUCOSA; MUCOSAL IMMUNITY; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIGENS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL TRANSPORT; CHEMOKINES; DENDRITIC CELLS; EPITHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, MUCOSAL; MICE; MUCOUS MEMBRANE; RECEPTORS, FC;

EID: 33645452204     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.29.16     Document Type: Article

References (91)

1. Tsukita S, et al.: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285–293, 2001.
2. Kindon H, et al.: Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 109: 516–523, 1995.
3. Bals R: Epithelial antimicrobial peptides in host defense against infection. Respir Res 1: 141–150, 2000.
4. Jones DE, Bevins CL: Defensin-6mRNAin human Paneth cells: Implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 315: 187–192, 1993.
5. Jones DE, Bevins CL: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267: 23216–23225, 1992.
6. Ouellette AJ, Lualdi JC: A novel mouse gene family coding for cationic, cysteine-rich peptides. Regulation in small intestine and cells of myeloid origin. J Biol Chem 265: 9831–9837, 1990.
7. Ayabe T, et al.: Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113–118, 2000.
8. Wilson CL, et al.: Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113–117, 1999.
9. Ghosh D, et al.: Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3: 583–590, 2002.
10. Ghoos Y, Vantrappen G: The cytochemical localization of lysozyme in Paneth cell granules. Histochem J 3: 175–178, 1971.
11. Dubouix A, et al.: Bactericidal properties of group IIa secreted phospholipase A (2) against Pseudomonas aeruginosa clinical isolates. J Med Microbiol 52: 1039–1045, 2003.
12. O’Neil DA, et al.: Expression and regulation of the human β-defensins hBD-l and hBD-2in intestinal epithelium. J Immunol 163: 6718–6724, 1999.
13. Harder J, et al.: Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707–5713, 2001.
14. Garcia JR, et al.: Human β-defensin 4: A novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. Faseb J 15: 1819–1821, 2001.
15. Hase K, et al.: Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70: 953–963, 2002.
16. Hase K, et al.: Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125: 1613–1625, 2003.
17. Salzman NH, et al.: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522–526, 2003.
18. Nizet V, et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454–457, 2001.
19. Iimura M, et al.: Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174: 4901–4907, 2005.
20. Smith J J, et al.: Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 229–236, 1996.
21. Goldman MJ, et al.: Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553–560, 1997.
22. Ogura Y, et al.: A frameshift mutation in N0D2 associated with susceptibility to Crohn's disease. Nature 411: 603–606, 2001.
23. Hugot JP, et al.: Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603, 2001.
24. Inohara N, et al.: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509–5512, 2003.
25. Girardin SE, et al.: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869–8872, 2003.
26. Ogura Y, et al.: Expression of NOD2 in Paneth cells: A possible link to Crohn's ileitis. Gut 52: 1591–1597, 2003.
27. Lala S, et al.: Crohn's disease and the NOD2 gene: A role for paneth cells. Gastroenterology 125: 47–57, 2003.
28. Kobayashi KS, et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731–734, 2005.
29. Watanabe T, et al.: N0D2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800–808, 2004.
30. Maeda S, et al.: Nod2 mutation in Crohn's disease potentiates NF-kB activity and IL-lβ processing. Science 307: 734–738, 2005.
31. Yang SK, et al.: Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113: 1214–1223, 1997.
32. McCormick BA, et al.: Salmonella typhimurium attachment to human intestinal epithelial monolayers: Transcellular signalling to subepithelial neutrophils. J Cell Biol 123: 895–907, 1993.
33. Jung HC, et al.: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55–65, 1995.
34. Yang D, et al.: β-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525–528, 1999.
35. De Y, et al.: LL-37, the neutrophil granule and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192: 1069–1074, 2000.
36. Cole AM, et al.: Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167: 623–627, 2001.
37. Kim JM, et al.: Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 102: 1815–1823, 1998.
38. Zychlinsky A, et al.: Shigella flexneri induces apoptosis in infected macrophages. Nature 358: 167–169, 1992.
39. Monack DM, et al.: Salmonella typhimurium invasion induces apoptosis in infected macro-phages. Proc Natl Acad Sci USA 93: 9833–9838, 1996.
40. Kunkel EJ, Butcher EC: Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1–4, 2002.
41. Hase K, et al.: The Membrane-Bound Chemokine CXCL16 Expressed on Follicle-Associated Epithelium and M Cells Mediates Lympho-Epithelial Interaction in GALT. J Immunol 176: 43–51, 2006.
42. Zhao X, et al.: CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J Immunol 171: 2797–2803, 2003.
43. Iwasaki A, Kelsall BL: Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J Exp Med 191: 1381–1394, 2000.
44. Abel S, et al.: The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362–6372, 2004.
45. Gough PJ, et al.: A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 172: 3678–3685, 2004.
46. Vinuesa CG, et al.: Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 5: 853–865, 2005.
47. Kunkel EJ, et al.: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 192: 761–768, 2000.
48. Svensson M, et al.: CCL25 mediates the localization of recently activated CD8αβ (+) lymphocytes to the small-intestinal mucosa. J Clin Invest 110: 1113–1121, 2002.
49. Bowman EP, et al.: The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 195: 269–275, 2002.
50. Lazarus NH, et al.: A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 170: 3799–3805, 2003.
51. Kunkel EJ, et al.: CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 111: 1001–1010, 2003.
52. Topping DL, Clifton PM: Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81: 1031–1064, 2001.
53. Ziegler TR, et al.: Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr 23: 229–261, 2003.
54. Weintraub A, et al.: Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 183: 425–431, 1989.
55. Golenbock DT, et al.: Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266: 19490–19498, 1991.
56. Jijon H, et al.: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358–1373, 2004.
57. Kelly D, et al.: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 5: 104-ll2, 2004.
58. Abreu MT, et al.: Decreased expression of Toll-like receptor-4and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609–1616, 2001.
59. Hornef MW, et al.: Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 195: 559–570, 2002.
60. Fernandez MI, et al.: Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739–749, 2003.
61. Gewirtz AT, et al.: Cutting edge: Bacterial lagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167: 1882–1885, 2001.
62. Sierro F, et al.: Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 98: 13722–13727, 2001.
63. Inohara N, et al.: Nodl, an Apaf-1-like acti-vatorofcaspase-9 and nuclear factor-kB. J Biol Chem 274: 14560–14567, 1999.
64. Chamaillard M, et al.: An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4: 702–707, 2003.
65. Kim JG, et al.: Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect Immun 72: 1487–1495, 2004.
66. Girardin SE, et al.: CARD4/Nodl mediates NF-kB and JNK activation by invasive Shigella flexneri. EMBO Rep 2: 736–742, 2001.
67. Savkovic SD, et al.: Activation of NF-kBinin-testinal epithelial cells by enteropathogenic Es cherichia coli. Am J Physiol 273: C1160-C1167, 1997.
68. Sharma SA, et al.: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 63: 1681–1687, 1995.
69. Huang J, et al.: Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun 63: 1732–1738, 1995.
70. Viala J, et al.: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166–1174, 2004.
71. Goosney DL, et al.: Gut feelings: Enteropathogenic E. coli (EPEC) interactions with the host. Annu Rev Cell Dev Biol 16: 173–189, 2000.
72. Buttner D, Bonas U: Port of entry-the type III secretion translocon. Trends Microbiol 10: 186–192, 2002.
73. Mowat AM: Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3: 331–341, 2003.
74. Kiyono H, Fukuyama S: NALT-versus Peyer’s-patch-mediated mucosal immunity. Nat Rev Immunol 4: 699–710, 2004.
75. Owen RL: Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: An ultrastructural study. Gastroenterology 72: 440–451, 1977.
76. Kraehenbuhl JP, Neutra MR: Epithelial M cells: Diferentiation and function. Annu Rev Cell Dev Biol 16: 301–332, 2000.
77. Owen RL: Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches-a personal and historical perspective. Semin Immunol 11: 157–163, 1999.
78. Neutra MR, et al.: Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res 247: 537–546, 1987.
79. Mantis NJ, et al.: Selective adherence of IgA to murine Peyer's patch M cells: Evidence for a novel IgA receptor. J Immunol 169: 1844–1851, 2002.
80. Frey A, et al.: Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. J Exp Med 184: 1045–1059, 1996.
81. Jepson MA, Clark MA: Studying M cells and their role in infection. Trends Microbiol 6: 359–365, 1998.
82. Jang MH, et al.: Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 101: 6110–6115, 2004.
83. Hase K, et al.: Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and m cells. DNA Res 12: 127–137, 2005.
84. Rescigno M, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2: 361–367, 2001.
85. Niess JH, et al.: CX3CRl-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254–258, 2005.
86. Rimoldi M, et al.: Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 6: 507–514, 2005.
87. Soumelis V, et al.: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673–680, 2002.
88. Rojas R, Apodaca G: Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol 3: 944–955, 2002.
89. Phalipon A, et al.: Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17: 107–115, 2002.
90. Johansen FE, et al.: Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory componentd-eficient mice. J Exp Med 190: 915–922, 1999.
91. Yoshida M, et al.: Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20: 769–783, 2004.